Clincosm LogoSign in Get a demo

Ovarian Cancer

Showing NaN - NaN of 91
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mesothelioma, Mesotheliomas Pleural, Mesothelioma, Malignant Trial in Bethesda, Nashville (TC-510, Fludarabine,

Recruiting
  • Mesothelioma
  • +14 more
  • TC-510
  • +2 more
  • Nashville, Tennessee
    Sarah Cannon Research Institute
Jul 14, 2022

Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in United States (NT-I7,

Recruiting
  • Any Advanced Solid Tumors
  • +6 more
  • Tampa, Florida
  • +7 more
Jul 13, 2022

Relapsed/Refractory Solid Tumor Malignancies or Lymphoma, Ovarian Cancer Trial in United States (mRNA-2416, Durvalumab)

Terminated
  • Relapsed/Refractory Solid Tumor Malignancies or Lymphoma
  • Ovarian Cancer
  • mRNA-2416
  • Durvalumab
  • Aurora, Colorado
  • +8 more
Jul 7, 2022

Advanced Cancer, Metastatic Cancer, Ovarian Cancer Trial in United Kingdom, United States (ART0380, Gemcitabine, Irinotecan)

Recruiting
  • Advanced Cancer
  • +4 more
  • Denver, Colorado
  • +10 more
Jul 6, 2022

Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)

Recruiting
  • Oncology
  • +16 more
  • E-602
  • Pembrolizumab
  • Grand Rapids, Michigan
  • +4 more
May 27, 2022

Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer Trial in United States (PF-07104091 monotherapy dose escalation,

Recruiting
  • Small Cell Lung Cancer
  • +4 more
  • PF-07104091 monotherapy dose escalation
  • +8 more
  • Clive, Iowa
  • +22 more
Apr 26, 2022

Ovarian Cancer Trial in Hungary, United Kingdom, United States (EP0057, Olaparib tablets)

Recruiting
  • Ovarian Cancer
  • Lady Lake, Florida
  • +15 more
Mar 29, 2022

Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY314, Combination Therapy: PY314 +

Recruiting
  • Advanced Solid Tumor
  • +8 more
  • PY314
  • Combination Therapy: PY314 + Pembrolizumab
  • Scottsdale, Arizona
  • +12 more
Mar 28, 2022

Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content, Head Neck Cancer Squamous Cell Carcinoma, NSCLC Trial in

Recruiting
  • Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content
  • +12 more
  • Palo Alto, California
  • +9 more
Mar 24, 2022

Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

Completed
Has Results
  • Advanced Solid Tumors
  • +6 more
  • Cabiralizumab
  • Nivolumab
  • Scottsdale, Arizona
  • +38 more
Jan 5, 2022

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in United States (SL-172154)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Duarte, California
  • +8 more
Feb 23, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Breast Cancer, Ovarian Cancer, Endometrial Cancer Trial in Korea, Republic of, United States (FPA150, Pembrolizumab)

Completed
  • Breast Cancer
  • +3 more
  • FPA150
  • Pembrolizumab
  • Scottsdale, Arizona
  • +17 more
Jan 6, 2022

Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer Trial in Spain, United States (STRO-002)

Recruiting
  • Ovarian Cancer
  • +6 more
  • Tucson, Arizona
  • +25 more
Dec 20, 2021

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Carcinoma Trial in United States (Pazopanib, Doxil)

Terminated
Has Results
  • Ovarian Cancer
  • +2 more
  • Fort Myers, Florida
  • +3 more
Oct 4, 2021

Ovarian Cancer Trial in Worldwide (Prexasertib)

Completed
Has Results
  • Ovarian Cancer
  • Tucson, Arizona
  • +45 more
Sep 28, 2021

Ovarian Tumors, Ovarian Cancer Trial in Canada, United States (Niraparib)

Completed
Has Results
  • Ovarian Neoplasms
  • Ovarian Cancer
  • Chandler, Arizona
  • +54 more
Sep 24, 2021

Tumor, Ovarian Cancer Trial in Belgium, United Kingdom, United States (NKTR-102 q14d, NKTR-102 q21d)

Completed
Has Results
  • Tumor
  • Ovarian Cancer
  • NKTR-102 q14d
  • NKTR-102 q21d
  • Highland, California
  • +19 more
Jul 9, 2021

Malignant Solid Tumors, Lymphoma, Ovarian Cancer Trial in Canada, United States (AZD5153, Olaparib)

Completed
  • Malignant Solid Tumors
  • +5 more
  • Sarasota, Florida
  • +3 more
May 5, 2021

Advanced Solid Tumors, Ovarian Cancer, Breast Cancer Trial in Canada, France, United States (SY-1365 (Part 1), Carboplatin,

Terminated
  • Advanced Solid Tumors
  • +2 more
  • SY-1365 (Part 1)
  • +5 more
  • Birmingham, Alabama
  • +19 more
Mar 5, 2021

Ovarian Cancer Trial in United Kingdom, United States (NUC-1031 500 mg, NUC-1031 750mg)

Terminated
Has Results
  • Ovarian Cancer
  • NUC-1031 500 mg
  • NUC-1031 750mg
  • Phoenix, Arizona
  • +16 more
Feb 16, 2021

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Worldwide (Rucaparib)

Completed
Has Results
  • Ovarian Cancer
  • +3 more
  • San Francisco, California
  • +15 more
Jan 19, 2021

Compare Fallopian Tube Cells Collected by Cytuity With Removed

Completed
Has Results
  • Fallopian Tube Cancer
  • +10 more
  • Hysteroscopic cell sampling of the fallopian tube
  • San Diego, California
  • +9 more
Dec 30, 2020